companydata.dkcompanydata.dk

Cystotech Invest ApS: Financial statements 2025

CVR: 43238191

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Cystotech Invest ApS (CVR 43238191) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -24,281 and a net result of DKK -24,281 compared with DKK -14,849 the year before. Equity in the 2025 report amounted to DKK 8,804,268. The solvency ratio was 99.9%.

Gross Profit
DKK -24,281
Profit/Loss
DKK -24,281
Equity
DKK 8,804,268
Total Assets
DKK 8,811,018
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--24K-24K8.8M0
2024--15K-15K6.6M0
2023--22K-22K5.4M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Cystotech Invest ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Cystotech Invest ApS: The 2024 annual report is outJan 29, 2025

Cystotech Invest ApS has published its annual report for 2024. Gross profit came to DKK -14,849, and the net result was DKK -14,849.

About Cystotech Invest ApS

Cystotech Invest ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2022. The company is registered under the industry Investering for egen regning. The management consists of Morten Petersen. The board consists of Bo Wase, Flemming Frandsen, Morten Petersen and Ole Niels Jakob Jensen. The company's owners include WAP HOLDING ApS, MORTEN PETERSEN ApS and POUL CARSTENSEN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -24,281 and a net result of DKK -24,281 compared with DKK -14,849 the year before. Equity in the 2025 report amounted to DKK 8,804,268.

Source: annual report 2025, Danish Business Authority

Other financial years